Rymti (etanercept)

pCPA File Number: 22082

Negotiation Status:

Concluded with an LOI

Indication(s):

Ankylosing Spondylitis, Plaque Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis and Polyarticular Juvenile Idiopathic Arthritis

Sponsor/Manufacturer:

Lupin Pharma Canada Ltd.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2023-02-22

Negotiation Process Concluded:

2023-10-04